(PharmaNewsWire.Com, May 17, 2017 ) The Asia-Pacific Melanoma Therapeutics Market research report, published by Market Data Forecast estimates that the market itself was worth $0.58 billion in 2016 and expected to grow at a CAGR of 16.40%, to reach $1.24 billion by 2021 with a cumulative growth rate of $0.66 billion in the span of five years.
Melanoma is usually, but not always, a cancer of the skin. It is easier to detect, unlike other cancers, since it can be seen on the skin. It is difficult to treat if left undetected and reaches stage IV(metastatic melanoma) in which the disease spreads to the rest of the body. Research in this field states that about 90% of melanoma cases are due to over-exposure to UV rays from natural or artificial sources.
In recent times, immune checkpoint inhibitors like pembrolizumab (Keytruda, nivolumab (Opdivo), and ipilimumab (Yervoy) block proteins that normally suppress the T-cell immune response against melanoma cells are being used to help melanoma patients lead longer lives. Researchers are now trying to combine various forms of immunotherapies to treat the condition. Vaccines and target therapies are some of the other treatments in use.
The report also presents detailed analysis of multitude of factors affecting the endoscopy devices market bearing either positive or negative outcomes. Some of those factors are: • Rise in number of Melanoma cases • Increasing awareness of Melanoma • Large population base • Poor accessibility of proper cancer care • Volatile economies prevalent in the region
For granular level understanding the Melanoma Therapeutics Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. The Asia-Pacific Melanoma Therapeutics market is segmented based on cancer stage, cancer type, diagnosis, and treatment. The market for Melanoma Therapeutics, on the basis of cancer stage is segmented into Stage 0, Stage I, Stage II, Stage III, Stage IV. On the basis of cancer type, the Melanoma Therapeutics market is segmented into Nodular melanoma, Acral lentiginous melanoma, Superficial spreading melanoma, Lentigno maligna melanoma, Amelanotic melanoma, and Others. On the basis of diagnosis, the Melanoma Therapeutics market is segmented into Ultrasound, Blood Tests, Dermatoscopy, Sentinel lymph node biopsy, X-rays, CT Scan. On the basis of treatment, the Melanoma Therapeutics market is segmented into early melanoma and advanced melanoma. Advanced melanoma is further sub-segmented into Biological therapy, Targeted therapy, Surgery, Chemotherapy, Radiotherapy, Immunotherapy.
The Asia-Pacific Melanoma Therapeutics market is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific Melanoma Therapeutics market is projected to grow at the highest CAGR during the forecast period due to reasons such as large population base and rising prevalence of melanoma. China is the largest market for Melanoma Therapeutics in this region followed by India.
The major companies dominating the market in this region are Bristol-Myers, Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi Sankyo, and Pfizer Inc.
The Asia-Pacific Water Endoscopic Devices Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
